Author

Nathaniel P. Oberholtzer

Observed names: Nathan Oberholtzer, Nathaniel Oberhoeltzer, Nathaniel Oberholtzer

Institutions: Medical University of South Carolina, MUSC Hollings Cancer Center

Observed institutions: Medical University of South Carolina, MUSC Hollings Cancer Center, University of Virginia

ORCID: 0000-0002-9080-5130

Observed ORCID: 0000-0002-9080-5130

OpenAlex ID: A5055086428

Pannexin 1 is required for full activation of insulin-stimulated glucose uptake in adipocytes

2015 · Samantha E. Adamson, Akshaya K. Meher, et al. · Molecular Metabolism · 77

PDF

Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer

2024 · Mustafa Emre Gedik, Ozge Saatci, et al. · Cancer Research · 37

Adaptive thermogenesis in brown adipose tissue involves activation of pannexin-1 channels

2020 · Subramanian Senthivinayagam, Vlad Serbulea, et al. · Molecular Metabolism · 33

Adoptive Transfer of Regulatory Immune Cells in Organ Transplantation

2021 · Nathaniel Oberholtzer, Carl Atkinson, et al. · Frontiers in Immunology · 27

PDF

H 2 S-Prdx4 axis mitigates Golgi stress to bolster tumor-reactive T cell immunotherapeutic response

2024 · Nathaniel Oberholtzer, Paramita Chakraborty, et al. · Science Advances · 23

PDF

Eosinophils and melanoma: Implications for immunotherapy

2021 · India Robinson, Gabriella Santa Lucia, et al. · Pigment Cell & Melanoma Research · 21

PDF

New Developments in T Cell Immunometabolism and Implications for Cancer Immunotherapy

2022 · Nathaniel Oberholtzer, Kristen M. Quinn, et al. · Cells · 19

PDF

Targeting protein tyrosine phosphatases for CDK6-induced immunotherapy resistance

2023 · Xueliang Gao, Yongxia Wu, et al. · Cell Reports · 10

Secreted frizzled-related protein 2 monoclonal antibody-mediated IFN-ϒ reprograms tumor-associated macrophages to suppress triple negative breast cancer

2025 · Lillian Hsu, Julie Siegel, et al. · Breast Cancer Research · 4

PDF

Role of antioxidants in modulating anti-tumor T cell immune resposne

2024 · Nathaniel Oberholtzer, Stephanie Mills, et al. · Advances in cancer research · 3

Single-Institution Experience Using Circulating Tumor DNA to Monitor Recurrence in Rectal Cancer

2026 · John C. Hulse, Kristen M. Quinn, et al. · Diseases of the Colon & Rectum · 2

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

2023 · Mustafa Emre Gedik, Ozge Saatci, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2

Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axis

2026 · Paramita Chakraborty, Shilpak Chatterjee, et al. · Nature Communications · 1

PDF

Key Interventions Related to Middle Ear Cholesteatoma: A Systematic Umbrella Review

2025 · Anna-Grace Chang, Nathaniel Oberholtzer, et al. · Otology & Neurotology · 1

Management of locally advanced rectal cancer: Clinical outcomes and use of ctDNA in a single-institution study

2026 · Kristen M. Quinn, John Hulse, et al. · Surgical Oncology Insight

PDF

Phase 1 dose escalation study of CD34 selected CD19 directed CAR T with metabolic programming in relapsed/refractory B-cell lymphoma.

2026 · Brian Hess, Elizabeth Goodwin Hill, et al. · Journal of Clinical Oncology

Phosphatidylcholine regulation via sphingosine kinase 2 inhibition drives immunogenic reprogramming of myeloid-derived suppressor cells 3701

2025 · Paramita Chakraborty, Shilpak Chatterjee, et al. · The Journal of Immunology

PDF

A Case of Allergic Fungal Rhinosinusitis With Intradural Extension and Cerebritis

2025 · Nathaniel Oberholtzer, Nicole Kloosterman, et al. · Otolaryngology

PDF

Data from Targeting TACC3 Induces Immunogenic Cell Death and Enhances T-DM1 Response in HER2-Positive Breast Cancer